HARMONY BIOSCIENCES HOLDINGS (HRMY)

US4131971040 - Common Stock

34.28  +0.39 (+1.15%)

After market: 34.28 0 (0%)

Buy % Consensus

77

ChartMill assigns a Buy % Consensus number of 77% to HRMY. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 48.05. This target is 40.18% above the current price.
HRMY was analyzed by 15 analysts. The buy percentage consensus is at 77. So analysts seem to be have mildly positive about HRMY.
In the previous month the buy percentage consensus was at a similar level.
HRMY was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 34.2828.2853.0448.0561.95 - -17.50% 54.73% 40.18% 80.72%
Up and Down Grades
Date Firm Action Rating
2024-12-17 HC Wainwright & Co. Initiate Buy
2024-10-30 Cantor Fitzgerald Maintains Overweight -> Overweight
2024-10-30 Needham Reiterate Buy -> Buy
2024-10-30 Oppenheimer Reiterate Outperform -> Outperform
2024-10-29 Needham Reiterate Buy -> Buy
2024-10-10 Mizuho Maintains Outperform -> Outperform
2024-10-10 Raymond James Reiterate Outperform
2024-10-02 Needham Reiterate Buy -> Buy
2024-09-24 Needham Reiterate Buy -> Buy
2024-09-12 Needham Reiterate Buy -> Buy
2024-09-10 UBS Initiate Buy
2024-08-08 Needham Reiterate Buy -> Buy
2024-08-06 Needham Reiterate Buy -> Buy
2024-06-25 Needham Reiterate Buy -> Buy
2024-06-24 Needham Reiterate Buy -> Buy
2024-06-21 Citigroup Initiate Buy
2024-05-01 Needham Maintains Buy -> Buy
2024-04-30 Needham Reiterate Buy -> Buy
2024-04-12 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-04-11 Needham Reiterate Buy -> Buy
2024-04-09 Needham Reiterate Buy -> Buy
2024-03-28 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-02-27 Mizuho Maintains Buy -> Buy
2024-02-23 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-02-23 Needham Maintains Buy -> Buy
2024-02-22 Needham Reiterate Buy -> Buy
2024-02-16 Mizuho Maintains Buy -> Buy
2024-01-09 Goldman Sachs Maintains Sell -> Sell
2024-01-02 B of A Securities Downgrade Neutral -> Underperform
2023-11-01 Needham Reiterate Buy -> Buy